WaveMan · Form 4
Huang Jane insider trades
> Search tickers & screens ⌘K
LIVE

Huang Jane insider trades

Huang Jane has filed 28 Form 4s with the SEC that we hold, for Prelude Therapeutics Inc (PRLD) (President, CMO), BeOne Medicines Ltd. (BGNE) (CMO, Hematology) and Protara Therapeutics, Inc. (TARA) (Director). Across all of them we count 0 purchases worth $0 and 55 sales worth $16.3M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 8,177 shares of BeOne Medicines Ltd. worth $2.7M, dated 2021-07-15. The first filing on our record is dated 2021-07-19 and the latest 2026-06-16.

Prelude Therapeutics Inc (PRLD)

President, CMO · 15 filings · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-04-06S, sale reported on Form 413,280$81.3K2023-04-06

BeOne Medicines Ltd. (BGNE)

CMO, Hematology · 8 filings · 54 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-07-15S, sale reported on Form 42,379$786.3K2021-07-19
2021-07-15S, sale reported on Form 46,523$2.2M2021-07-19
2021-07-15S, sale reported on Form 48,177$2.7M2021-07-19
2021-07-15S, sale reported on Form 42,823$941.9K2021-07-19
2021-07-15S, sale reported on Form 41,000$334.9K2021-07-19
2021-07-15S, sale reported on Form 498$32.9K2021-07-19
2021-09-01S, sale reported on Form 4542$168.3K2021-09-02
2021-09-02S, sale reported on Form 4545$178.3K2021-09-02
2021-09-13S, sale reported on Form 41$3632021-09-15
2021-09-13S, sale reported on Form 41,581$573.6K2021-09-15
2021-09-13S, sale reported on Form 41,800$647.8K2021-09-15
2021-09-13S, sale reported on Form 41,700$610.6K2021-09-15
2021-09-13S, sale reported on Form 41,300$464.8K2021-09-15
2021-09-13S, sale reported on Form 41,400$499.0K2021-09-15
2021-09-13S, sale reported on Form 44,219$1.5M2021-09-15
2021-09-13S, sale reported on Form 4900$324.9K2021-09-15
2021-09-20S, sale reported on Form 4100$41.1K2021-09-22
2021-09-20S, sale reported on Form 4536$210.3K2021-09-22
2021-09-20S, sale reported on Form 4328$129.0K2021-09-22
2021-09-20S, sale reported on Form 4913$360.8K2021-09-22
2021-09-20S, sale reported on Form 4700$277.2K2021-09-22
2021-09-20S, sale reported on Form 4700$278.0K2021-09-22
2021-09-20S, sale reported on Form 4790$314.7K2021-09-22
2021-09-20S, sale reported on Form 4400$159.6K2021-09-22
2021-09-20S, sale reported on Form 4400$160.2K2021-09-22
2021-09-20S, sale reported on Form 4583$234.3K2021-09-22
2021-09-20S, sale reported on Form 4200$81.4K2021-09-22
2021-09-20S, sale reported on Form 4150$61.2K2021-09-22
2021-09-20S, sale reported on Form 4100$40.9K2021-09-22
2021-09-20S, sale reported on Form 4100$39.1K2021-09-22
2021-10-19S, sale reported on Form 4200$72.4K2021-10-21
2021-10-19S, sale reported on Form 4100$37.8K2021-10-21
2021-10-19S, sale reported on Form 4200$75.3K2021-10-21
2021-10-19S, sale reported on Form 4400$150.0K2021-10-21
2021-10-19S, sale reported on Form 4400$149.5K2021-10-21
2021-10-19S, sale reported on Form 4100$37.2K2021-10-21
2021-10-19S, sale reported on Form 4100$37.0K2021-10-21
2021-11-17S, sale reported on Form 4200$75.2K2021-11-19
2021-11-17S, sale reported on Form 4300$116.4K2021-11-19
2021-11-17S, sale reported on Form 4100$38.0K2021-11-19
2021-11-17S, sale reported on Form 4300$113.1K2021-11-19
2021-11-17S, sale reported on Form 4100$38.2K2021-11-19
2021-11-17S, sale reported on Form 4100$37.8K2021-11-19
2021-11-17S, sale reported on Form 4200$76.3K2021-11-19
2021-11-17S, sale reported on Form 4100$38.5K2021-11-19
2021-11-17S, sale reported on Form 4100$38.4K2021-11-19
2021-12-01S, sale reported on Form 4519$188.1K2021-12-02
2021-12-01S, sale reported on Form 4530$189.4K2021-12-02
2021-12-14S, sale reported on Form 4300$82.4K2021-12-16
2021-12-14S, sale reported on Form 4200$56.3K2021-12-16
2021-12-14S, sale reported on Form 4100$27.9K2021-12-16
2021-12-14S, sale reported on Form 4100$28.5K2021-12-16
2021-12-14S, sale reported on Form 4300$83.1K2021-12-16
2021-12-14S, sale reported on Form 4500$139.1K2021-12-16

Protara Therapeutics, Inc. (TARA)

Director · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1683913) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms